HLB Life Science, Individual Investors Focused... Stock Price -7.39%...

Recently, there has been a surge in search frequency for HL Biopharma, known as an engineering service company related to energy saving.

As of 12:32 PM on the 22nd, the stock price of HL Biopharma is 31,950 KRW, down 7.39% from the previous day, with a trading volume of 3,239,761 shares, which is about 57.56% of the 5-day average trading volume. Foreign investors are tentatively reported to have net purchased 10,000 shares today.

On September 21, HL Biopharma became a market issue with a 21% increase following the Phase 3 clinical trial results of 'Riboceranib'.

[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.